HPV vaccine uptake in men who have sex with men in Scotland
Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first y...
Saved in:
| Published in | Vaccine Vol. 37; no. 37; pp. 5513 - 5514 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
03.09.2019
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0264-410X 1873-2518 1873-2518 |
| DOI | 10.1016/j.vaccine.2018.11.081 |
Cover
| Abstract | Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8–55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease. |
|---|---|
| AbstractList | Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8–55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease. Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8-55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease.Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8-55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease. AbstractHuman papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8–55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease. |
| Author | Pollock, K.G. Steedman, N. Wrigglesworth, S. McMaster, D. Wallace, L.A. |
| Author_xml | – sequence: 1 givenname: K.G. surname: Pollock fullname: Pollock, K.G. email: Kevin.pollock@gcu.ac.uk organization: School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK – sequence: 2 givenname: L.A. surname: Wallace fullname: Wallace, L.A. organization: School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK – sequence: 3 givenname: S. surname: Wrigglesworth fullname: Wrigglesworth, S. organization: Information Services Division, Gyle Square, Edinburgh, UK – sequence: 4 givenname: D. surname: McMaster fullname: McMaster, D. organization: Information Services Division, Gyle Square, Edinburgh, UK – sequence: 5 givenname: N. surname: Steedman fullname: Steedman, N. organization: Information Services Division, Gyle Square, Edinburgh, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30545714$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNklFrFDEUhYNU7Hb1JygDvvgyY24ySWYpKlLUCgWFqvgWMskdNtvZzHYys7X_3oy79mFB1qdAcs7HzTn3jJyELiAhz4EWQEG-XhVbY60PWDAKVQFQ0AoekRlUiudMQHVCZpTJMi-B_jwlZzGuKKWCw-IJOeVUlEJBOSPnl19_ZHtSNm4Gc4OZD9kaQ3a37LKl2WIW8Vd254fln9v0eG27oTXBPSWPG9NGfLY_5-T7xw_fLi7zqy-fPl-8v8qtqNiQc1UbKZxVwolGGqekoI2BesGqukHlVF0Zmca2zDKuJLMLUZasEsZSB04yPievdtxN392OGAe99tFim2bAboyaMQaUi4rz41IQSirGxUR9eSBddWMf0kcSUCleiinKOXmxV431Gp3e9H5t-nv9N8EkEDuB7bsYe2weJED11JRe6X2-empKA-jUVPKdH_isH8zguzD0xrdH3e92bky5bz32OlqPwaLzPdpBu84fJbw9INjWB29Ne4P3GB-yAB2Zpvp62qVplaDiIFM2CfDm34D_GOA3eDHYLg |
| CitedBy_id | crossref_primary_10_1111_jdv_15575 crossref_primary_10_1177_09564624241273778 crossref_primary_10_1080_21645515_2024_2440956 crossref_primary_10_1016_j_puhe_2021_05_012 crossref_primary_10_1007_s10461_024_04569_8 crossref_primary_10_1016_j_vaccine_2021_05_013 crossref_primary_10_3389_fpubh_2022_891991 crossref_primary_10_1177_25151355241308313 crossref_primary_10_1016_j_vaccine_2021_05_031 crossref_primary_10_1177_21501319221110411 crossref_primary_10_3390_vaccines9111218 crossref_primary_10_1007_s10096_021_04229_y crossref_primary_10_1158_1055_9965_EPI_23_0626 crossref_primary_10_1080_21645515_2020_1756151 crossref_primary_10_1186_s12889_021_12396_y crossref_primary_10_1007_s13178_023_00921_0 crossref_primary_10_3389_fmed_2022_904873 crossref_primary_10_2196_21465 crossref_primary_10_1177_09564624231165078 crossref_primary_10_3390_v13050906 |
| Cites_doi | 10.1136/jech-2013-202620 10.1200/JCO.2013.50.3870 10.1177/0956462418775510 10.1016/S1473-3099(17)30653-9 10.1016/S1473-3099(17)30468-1 10.1200/JCO.2012.44.5486 |
| ContentType | Journal Article |
| Copyright | 2018 Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Sep 3, 2019 |
| Copyright_xml | – notice: 2018 – notice: Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Sep 3, 2019 |
| DBID | AAYXX CITATION NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7S9 L.6 |
| DOI | 10.1016/j.vaccine.2018.11.081 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database (ProQuest) ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef PubMed Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA Research Library Prep MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-2518 |
| EndPage | 5514 |
| ExternalDocumentID | 30545714 10_1016_j_vaccine_2018_11_081 S0264410X18316451 1_s2_0_S0264410X18316451 |
| Genre | Journal Article |
| GeographicLocations | England Scotland United Kingdom--UK Northern Ireland Wales |
| GeographicLocations_xml | – name: England – name: Northern Ireland – name: Wales – name: United Kingdom--UK – name: Scotland |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP AAIAV ABLVK ABYKQ AESVU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII CITATION NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c582t-37ba65dc75d5f6ad7650fa1b928bfe7d7b8a6187c2c23762c9544285ac0d1d623 |
| IEDL.DBID | AIKHN |
| ISSN | 0264-410X 1873-2518 |
| IngestDate | Fri Sep 05 05:06:28 EDT 2025 Thu Sep 04 16:01:57 EDT 2025 Wed Aug 13 06:15:30 EDT 2025 Thu Apr 03 06:58:29 EDT 2025 Tue Jul 01 01:06:44 EDT 2025 Thu Apr 24 23:09:31 EDT 2025 Fri Feb 23 02:35:15 EST 2024 Sun Feb 23 10:19:57 EST 2025 Tue Aug 26 19:08:46 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 37 |
| Keywords | Vaccine Sexual health MSM HPV |
| Language | English |
| License | Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c582t-37ba65dc75d5f6ad7650fa1b928bfe7d7b8a6187c2c23762c9544285ac0d1d623 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://researchonline.gcu.ac.uk/en/publications/92c29b90-4b1c-4a12-ad1d-1cdee827f177 |
| PMID | 30545714 |
| PQID | 2277345187 |
| PQPubID | 105530 |
| PageCount | 2 |
| ParticipantIDs | proquest_miscellaneous_2221035833 proquest_miscellaneous_2157672352 proquest_journals_2277345187 pubmed_primary_30545714 crossref_primary_10_1016_j_vaccine_2018_11_081 crossref_citationtrail_10_1016_j_vaccine_2018_11_081 elsevier_sciencedirect_doi_10_1016_j_vaccine_2018_11_081 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X18316451 elsevier_clinicalkey_doi_10_1016_j_vaccine_2018_11_081 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09-03 |
| PublicationDateYYYYMMDD | 2019-09-03 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-03 day: 03 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands – name: Kidlington |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2019 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Piketty C, Selinger-Leneman H, Bouvier AM et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012;30:4360–6. Cameron, Cuschieri, Pollock (b0005) 2018 Public Health England, 2018. Health and Social Care Northern Ireland Public Health Agency, 2017. Chief Medical Offer Directorate, 2017. [accessed 23rd October 2018]. Knapper, Birley, Parker (b0035) 2018; 29 Joint Committee on Vaccination and Immunisation, 2015. Lin, Franceschi, Clifford (b0040) 2017; 18 Kavanagh, Pollock, Cuschieri (b0030) 2017; 17 Sinka, Kavanagh, Gordon (b0055) 2014; 68 [accessed 19th October 2018]. Chaturvedi, Anderson, Lortet-Tieulent (b0010) 2013; 31 10.1016/j.vaccine.2018.11.081_b0025 Sinka (10.1016/j.vaccine.2018.11.081_b0055) 2014; 68 10.1016/j.vaccine.2018.11.081_b0015 Knapper (10.1016/j.vaccine.2018.11.081_b0035) 2018; 29 Lin (10.1016/j.vaccine.2018.11.081_b0040) 2017; 18 Cameron (10.1016/j.vaccine.2018.11.081_b0005) 2018 10.1016/j.vaccine.2018.11.081_b0050 Chaturvedi (10.1016/j.vaccine.2018.11.081_b0010) 2013; 31 10.1016/j.vaccine.2018.11.081_b0020 Kavanagh (10.1016/j.vaccine.2018.11.081_b0030) 2017; 17 10.1016/j.vaccine.2018.11.081_b0045 |
| References_xml | – volume: 18 start-page: 198 year: 2017 end-page: 206 ident: b0040 article-title: Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis publication-title: Lancet Infect Dis – reference: Public Health England, 2018. – reference: [accessed 19th October 2018]. – reference: Piketty C, Selinger-Leneman H, Bouvier AM et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012;30:4360–6. – reference: Joint Committee on Vaccination and Immunisation, 2015. – volume: 17 start-page: 1293 year: 2017 end-page: 1302 ident: b0030 article-title: Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study publication-title: Lancet Infect Dis – year: 2018 ident: b0005 article-title: Baseline HPV prevalence in rectal swabs from men attending sexual health clinics in Scotland: assessing the potential impact of a selective HPV vaccination programme for men who have sex with men publication-title: STD – reference: [accessed 23rd October 2018]. – volume: 31 start-page: 4550 year: 2013 end-page: 4559 ident: b0010 article-title: Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers publication-title: J Clin Oncol – reference: Health and Social Care Northern Ireland Public Health Agency, 2017. – reference: Chief Medical Offer Directorate, 2017. – volume: 29 start-page: 1106 year: 2018 end-page: 1109 ident: b0035 article-title: Audit of a human papillomavirus vaccine programme for men who have sex with men delivered through an Integrated Sexual Reproductive Health service publication-title: Int J STD AIDS – volume: 68 start-page: 57 year: 2014 end-page: 63 ident: b0055 article-title: Achieving high and equitable coverage of adolescent HPV vaccine in Scotland publication-title: J Epidemiol Community Health – volume: 68 start-page: 57 year: 2014 ident: 10.1016/j.vaccine.2018.11.081_b0055 article-title: Achieving high and equitable coverage of adolescent HPV vaccine in Scotland publication-title: J Epidemiol Community Health doi: 10.1136/jech-2013-202620 – volume: 31 start-page: 4550 issue: 36 year: 2013 ident: 10.1016/j.vaccine.2018.11.081_b0010 article-title: Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers publication-title: J Clin Oncol doi: 10.1200/JCO.2013.50.3870 – year: 2018 ident: 10.1016/j.vaccine.2018.11.081_b0005 article-title: Baseline HPV prevalence in rectal swabs from men attending sexual health clinics in Scotland: assessing the potential impact of a selective HPV vaccination programme for men who have sex with men publication-title: STD – ident: 10.1016/j.vaccine.2018.11.081_b0015 – volume: 29 start-page: 1106 year: 2018 ident: 10.1016/j.vaccine.2018.11.081_b0035 article-title: Audit of a human papillomavirus vaccine programme for men who have sex with men delivered through an Integrated Sexual Reproductive Health service publication-title: Int J STD AIDS doi: 10.1177/0956462418775510 – volume: 18 start-page: 198 year: 2017 ident: 10.1016/j.vaccine.2018.11.081_b0040 article-title: Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30653-9 – volume: 17 start-page: 1293 year: 2017 ident: 10.1016/j.vaccine.2018.11.081_b0030 article-title: Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30468-1 – ident: 10.1016/j.vaccine.2018.11.081_b0045 doi: 10.1200/JCO.2012.44.5486 – ident: 10.1016/j.vaccine.2018.11.081_b0020 – ident: 10.1016/j.vaccine.2018.11.081_b0025 – ident: 10.1016/j.vaccine.2018.11.081_b0050 |
| SSID | ssj0005319 |
| Score | 2.4055133 |
| Snippet | Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men... AbstractHuman papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5513 |
| SubjectTerms | Age Allergy and Immunology Gays & lesbians Girls Health services HIV HPV Human immunodeficiency virus Human papillomavirus Immunization men Mens health MSM Papillomaviridae Scotland Sexual health vaccination Vaccine Vaccines |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagCMQFwfJaKMhIqKdmGzt2nIoDQohqhQRaqQ_lZvkVtQWShWQL_feMHSe50JZrkk92PPZ4xv5mBqG3mTNWq0ol1vijm8qpRFnHE6oyXnEtUmoCQfZrvjxmn0texgO3NtIqB50YFLVtjD8j36NUiIxxUoj365-Jrxrlb1djCY3b6E5IXQbzWZRionhkobAHuBksYSQtpwievfPFhTL-6tqzu4pFSORJrtqbrrI9wx508BA9iMYj_tBL-xG65eoZutuXk7ycoXtf4kX5DO2s-pTUl7v4aIqwanfxDl5NyaoBMzvxfJgQlIsH-GP0brk6wbHreLPu1DeHz2r8w9X492mDT9WFw637g_0pbngKLw9N03ma5BN0fPDp6OMyiWUWEsML2oGK0Srn1ghueZUrK8BoqxTR-7TQlRNW6ELlMO6GGk-hAeFxBk4LVya1xIL59BRt1U3tniOstSDeoxIZUczuM20AkvHccpMXlSNzxIYBlibmIPelML7LgWx2LuPPSS8X8E8kyGWOFiNs3SfhuAmQD9KTQ4Qp6EQJ28RNQPEvoGvjym4lkS2VqTxMgyWZlqASwePkgCxGZDReeqPkfxrdHiaYHNuZ5vscvRlfw9r3Fzqqds0GviHgLQoKNvQ131Bw6jMfWzdHz_rJO44h6HrGBWEvru_AS3Qfetsz67JttNX92rhXYIp1-nVYb38B4GQwXA priority: 102 providerName: ProQuest |
| Title | HPV vaccine uptake in men who have sex with men in Scotland |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X18316451 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X18316451 https://dx.doi.org/10.1016/j.vaccine.2018.11.081 https://www.ncbi.nlm.nih.gov/pubmed/30545714 https://www.proquest.com/docview/2277345187 https://www.proquest.com/docview/2157672352 https://www.proquest.com/docview/2221035833 |
| Volume | 37 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTiBeEBQYgYGMhPa0tLETx6l4GtWmAqKq2If6Zjm2o3VAWpF0sBf-ds75qhCMIV7SNPEvcezL-S7-3RngVWi1SVWmfKPdp5vMKl8Zy32mQp7xVARMVwTZaTw5jd7N-XwLxm0sjKNVNrq_1umVtm6ODJvWHK4Wi-FxUI3lwRyFEm1-F0a9zcJRzHuwffD2_WS6YXqE1foerrzvAJtAnuHF4FJpN4PtSF7JoMrnSa8boq4zQauh6Og-3GtsSHJQV_MBbNm8D7frVSWv-nDnQzNf3oe9WZ2Z-mqfnGwCrYp9skdmm5zViOmfOVpMFZtLWvhDeD2ZnZGm6mS9KtUnSxY5-WJz8u18Sc7VpSWF_U7cx9zqKJ481svSsSUfwenR4cl44jerLfiaJ6xETZOqmBstuOFZrIxA2y1TNB2xJM2sMCJNVEwToZl2TBrsQx6h78KVDgw1aEU9hl6-zO0TIGkqqHOsREhVZEZRqhES8thwHSeZpR5EbQNL3aQidytifJYt5-xCNg8nXb-gmyKxXzwYdLBVnYvjJkDc9p5sA01RNUocLW4Cij8BbdG84IWksmAykL8JoQdJh_xFjv_lprutgMnuPowJEeJ1E-HBy-40qgA3r6Nyu1xjGYpOo2BoSv-lDEPfPnQhdh7s1MLbtSGq_IgLGj39_7o_g7v4rybfhbvQK7-u7XO01sr0Bdwa_KC4FXOB22SM-_X7ib9vDqezjz8Bvp1AIw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD6aOnF5QVBgFAYYCfa0dLFjx5kQQlw2dWyrKnZR34xjOxoD0kLajf4pfiPHubQvbONlr0k-2fGxj79jnwvAy8gZm-pMB9b4o5vM6UBbJwKmI5GJVIbMlA6y_bh3xD8NxXAJ_jSxMN6tstGJpaK2I-PPyDcYkzLigiby7fhn4KtG-dvVpoRGNS123ewcTbbizc5HlO8rxra3Dj_0grqqQGBEwia4olIdC2uksCKLtZXIUTJN002WpJmTVqaJjrEZw4z3GMG-Co4cXWgTWmpjn-gAVf4y9xGtLVh-v9UffF44lURlKRE0bHjAaThcxAxtnHbPtPGX5d6fLOmWqUPpRbvhRWy33PW278Kdmq6Sd9X8ugdLLm_DjaqA5awNN_frq_k2rA2qJNizdXK4iOkq1skaGSzSYyOmfew9cMowYNLA78Pr3uCY1F0n0_FEf3Pka05-uJycn4zIiT5zpHC_iT83Lp_iywMzmnjHzAdwdC0ieAitfJS7R0DSVFJvw8mIam43eWoQEonYChMnmaMd4M0AK1NnPffFN76rxr3tVNU_p7xc0CJSKJcOdOewcZX24ypA3EhPNTGtqIUVbkxXAeW_gK6odUmhqCqYCtVBWHLXcIhKGG1cgchkjqzpUkWD_qfR1WaCqXk7ixXWgRfz16ht_BWSzt1oit9QtE8lQ9Z-yTeM0TDy0XwdWKkm73wMcXfhQlL--PIOPIdbvcP9PbW30999Arex55VfX7QKrcmvqXuKRHCSPqtXH4Ev173g_wJ-DW6H |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIiouCJbXlgJGgp6a3diJ41QIIURZbSlUK_Wh3IxfUWkhWUi2Zf8av45xnhfacul1k5G9Gc_4G_ubGYReBVYbJVPpGe2OblIrPWks86gMWMoU96muCLL70fQo_JSwZAX9aXNhHK2y9YmVoza5dmfkY0o5D0JGYj5OG1rEbGfybv7Tcx2k3E1r206jXiJ7dnkB4VvxdncHdP2a0snHww9Tr-kw4GkW0xKsS8mIGc2ZYWkkDQe8kkqitmmsUssNV7GMYEhNtWOPwLxZCHidSe0bYiJX9ADc_y0eAKoCW-IJ7-klQdVUBEKc0AuJn_TZQ-PT0bnU7trcMcviUVVElFy2L16Ge6v9b3IP3W2AK35fr7T7aMVmA3S7bmW5HKC1L80l_QBtzupy2MstfNhndxVbeBPP-kLZIDM4dlycKiEYt-IP0Jvp7Bg3U8eLeSnPLP6W4R82wxcnOT6R5xYX9jd2J8jVr_DwQOelo2g-REc3ooBHaDXLM_sEYaU4cdEcD4gMzXaoNIgELDJMR3FqyRCF7QcWuql_7tpwfBct0e1UNH9OOL1AbCRAL0M06sTmdQGQ6wSiVnuizW4Ffyxgi7pOkP9L0BaNVykEEQUVvjjwKxTrJ-COIdplIBl3kg1wqgHR_wy60S4w0Y3T29oQveweg99xl0kys_kC3iEQqXIK-P2KdyglfuDy-obocb14u28I-0zIOAnXr57AC7QGZi4-7-7vPUV3YOI1wS_YQKvlr4V9BoiwVM8r08Po603b-l9tEnFO |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HPV+vaccine+uptake+in+men+who+have+sex+with+men+in+Scotland&rft.jtitle=Vaccine&rft.au=Pollock%2C+K.G.&rft.au=Wallace%2C+L.A.&rft.au=Wrigglesworth%2C+S.&rft.au=McMaster%2C+D.&rft.date=2019-09-03&rft.issn=0264-410X&rft.volume=37&rft.issue=37&rft.spage=5513&rft.epage=5514&rft_id=info:doi/10.1016%2Fj.vaccine.2018.11.081&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_vaccine_2018_11_081 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X19X00341%2Fcov150h.gif |